China Meheco Co Ltd (600056 SHG) stock market data APIs
¥10.75
0.01(0.1%)
as of January 20, 2025
China Meheco Co Ltd Financial Data Overview
Price chart is built with
Anychart
China Meheco Group Co., Ltd. engages in the pharmaceutical business in China and internationally. The company exports and imports natural medicines, pharmaceutical chemicals, medical equipment, and health products; produces and distributes pharmaceutical and health care products; and operates retail chain pharmacies. Its products include bulk pharmaceutical chemicals antibiotic fermentation and chemical synthesis tablets, injections, capsules, etc.; antibiotics; medicines for the treatment of cardio-cerebrovascular diseases, chronic diseases, and diabetes; antiviral; anti-infectious agents; gastrointestinal drugs; non-steroidal anti-inflammatory drugs; anti-allergic agents; specialty botanicals; western medicine preparations; Chinese patent medicines and herbal pieces; medical equipment and supplies; biological products; chemical raw materials; and nutritional and healthcare products. The company also plants, processes, warehouses, and transports ginseng, licorice, ephedra, rhubarb, rheum officinale, astragalus membranaceus, scutellaria baicalensis, fennel, and other herbs. China Meheco Group Co., Ltd. was founded in 1984 and is based in Beijing, China.
Prev. Close
10.74
Open
10.75
Volume
7 747 K
High
10.85
Low
10.72
52 wk Range
9.47-13.88
Market Cap
16 036 M
P/E Ratio
17.8667
Shares Outstanding
1 496 M
Revenue
35 127 M
EPS
0.03
Beta
0.136
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get China Meheco Co Ltd data using free add-ons & libraries
Get China Meheco Co Ltd Fundamental Data
China Meheco Co Ltd Fundamental data includes:
- Net Revenue: 35 127 M
- EBITDA: 1 417 M
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2023-10-27
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
China Meheco Co Ltd News
New
Chinese drug makers’ shares plunge as Pfizer’s Paxlovid gains market share
Shares of Chinese pharmaceutical companies plunged Tuesday morning on Chinese bourses, continuing a slide that began in the face of competition from Pfizer's COVID-19 drug Paxlovid earlier this month. Continue reading
Pfizer to Sell Paxlovid in China as Covid Cases Surge
(Bloomberg) -- Pfizer Inc. clinched an agreement to sell its antiviral medication Paxlovid in China through a state-owned company, making the drug available to battle surging Covid-19 cases. Most Rea...
UPDATE 3-China Meheco to distribute Pfizer's COVID treatment in China
(Adds background on U.S. contract for Paxlovid, updates shares) HONG KONG, Dec 14 (Reuters) - China Meheco Group Co Ltd said on Wednesday it signed an agreement with Pfizer Inc to import and distribu...
CORRECTED-UPDATE 2-China Meheco to distribute Pfizer's COVID treatment in China
(Corrects to reflect deal with Huahai was in August not April in paragraph 5) HONG KONG, Dec 14 (Reuters) - China Meheco Group Co Ltd said on Wednesday it had signed an agreement with Pfizer to impor...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
